Teva Reaches ‘Modest’ Settlement With Georgia Over Price-Fixing Allegations
Israeli Giant Will Pay State $3.34m As Part Of Settlement
Executive Summary
Teva has made its third settlement with a US state following the Department of Justice’s price-fixing investigation, agreeing to pay Georgia $3.34m in exchange for the dismissal of all claims against the company and its affiliates.
You may also be interested in...
Teva Inks $4.35bn Nationwide US Opioids Settlement Agreement
Teva is to put more than $3bn in cash on the table over the next 13 years to resolve longstanding opioid-related claims against the company in the US.
Teva Agrees To $420m Securities Settlement For Alleged Price Fixing
Denying any wrongdoing or admission of liability, Teva has agreed to a proposed settlement of $420m with a class of investors following allegations that the firm had concealed the true nature of its increase in profits, which artificially inflated the price of Teva’s securities.
Teva State Settlement On Price-Fixing Could Be First Of Many
Teva has struck a $950,000 deal to settle US price-fixing litigation with the state of Mississippi, in what the firm anticipates could be the first of multiple settlements with individual US states.